Stock Events

Stock Events

Candel Therapeutics (CADL) Q1 2026 Earnings

12MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.54

-0.32

-0.09

0.13

Details

Expected EPS

-0.244411

Actual EPS

-0.54

Surprise EPS

-0.3

Surprise Percent

+120.94%

Description

Candel Therapeutics (CADL) has reported earnings of -0.54 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.